These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 31695027)
1. Molecular basis for chirality-regulated Aβ self-assembly and receptor recognition revealed by ion mobility-mass spectrometry. Li G; DeLaney K; Li L Nat Commun; 2019 Nov; 10(1):5038. PubMed ID: 31695027 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of C-Terminal Fragments of Amyloid β-Protein as Aβ Inhibitors: Do C-Terminal Interactions Play a Key Role in Their Inhibitory Activity? Zheng X; Wu C; Liu D; Li H; Bitan G; Shea JE; Bowers MT J Phys Chem B; 2016 Mar; 120(8):1615-23. PubMed ID: 26439281 [TBL] [Abstract][Full Text] [Related]
3. Ion mobility spectrometry combined with multivariate statistical analysis: revealing the effects of a drug candidate for Alzheimer's disease on Aβ1-40 peptide early assembly. Lazzaro S; Ogrinc N; Lamont L; Vecchio G; Pappalardo G; Heeren RMA Anal Bioanal Chem; 2019 Sep; 411(24):6353-6363. PubMed ID: 31407050 [TBL] [Abstract][Full Text] [Related]
10. Structural characterization of beta-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy. Ionuţ Iuraşcu M; Cozma C; Tomczyk N; Rontree J; Desor M; Drescher M; Przybylski M Anal Bioanal Chem; 2009 Dec; 395(8):2509-19. PubMed ID: 19838688 [TBL] [Abstract][Full Text] [Related]
11. Abeta(1-40) peptide radiopharmaceuticals for brain amyloid imaging: (111)In chelation, conjugation to poly(ethylene glycol)-biotin linkers, and autoradiography with Alzheimer's disease brain sections. Kurihara A; Pardridge WM Bioconjug Chem; 2000; 11(3):380-6. PubMed ID: 10821654 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical Data. Kocis P; Tolar M; Yu J; Sinko W; Ray S; Blennow K; Fillit H; Hey JA CNS Drugs; 2017 Jun; 31(6):495-509. PubMed ID: 28435985 [TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the hetero-assembly of β-amyloid peptide with islet amyloid polypeptide. Yan LM; Velkova A; Kapurniotu A Curr Pharm Des; 2014; 20(8):1182-91. PubMed ID: 23713771 [TBL] [Abstract][Full Text] [Related]
14. Identification and structural characterisation of carboxy-terminal polypeptides and antibody epitopes of Alzheimer's amyloid precursor protein using high-resolution mass spectrometry. Tian X; Cecal R; McLaurin J; Manea M; Stefanescu R; Grau S; Harnasch M; Amir S; Ehrmann M; St George-Hyslop P; Kohlmann M; Przybylski M Eur J Mass Spectrom (Chichester); 2005; 11(5):547-56. PubMed ID: 16322661 [TBL] [Abstract][Full Text] [Related]
16. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ Asadbegi M; Shamloo A ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950 [TBL] [Abstract][Full Text] [Related]
18. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease. Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549 [TBL] [Abstract][Full Text] [Related]
19. The effect of terminal groups and halogenation of KLVFF peptide on its activity as an inhibitor of β-amyloid aggregation. Khalili Samani E; Mofid MR; Malakoutikhah M J Pept Sci; 2020 Feb; 26(2):e3227. PubMed ID: 31845472 [TBL] [Abstract][Full Text] [Related]
20. Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's disease. Portelius E; Olsson M; Brinkmalm G; Rüetschi U; Mattsson N; Andreasson U; Gobom J; Brinkmalm A; Hölttä M; Blennow K; Zetterberg H J Alzheimers Dis; 2013; 33(1):85-93. PubMed ID: 22886024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]